Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

INTRODUCTION: This study explored the ability of plasma amyloid beta (Aβ)42/Aβ40 to identify brain amyloid deposition in cognitively unimpaired (CU) individuals. METHODS: Plasma Aβ was quantified with an antibody‐free high‐performance liquid chromatography tandem mass spectrometry method from Araclo...

Descripción completa

Detalles Bibliográficos
Autores principales: Allué, José Antonio, Pascual‐Lucas, María, Sarasa, Leticia, Castillo, Sergio, Sarasa, Manuel, Sáez, María Eugenia, Abdel‐Latif, Sara, Rissman, Robert A., Terencio, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236000/
https://www.ncbi.nlm.nih.gov/pubmed/37274930
http://dx.doi.org/10.1002/dad2.12451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236000/
https://www.ncbi.nlm.nih.gov/pubmed/37274930
http://dx.doi.org/10.1002/dad2.12451

Ejemplares similares